Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria
A lactic acid-producing bacteria, non-replicating technology, applied in the field of infant nutrition, can solve problems such as secretory IgA not mentioned
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0085] Example 1: Synergistic effect of an infant formula comprising non-replicating lactic acid producing bacteria selected from Bifidobacterium breve and Streptococcus thermophilus and non-digestible oligosaccharides on secretory IgA levels in infants
[0086] In a randomized, double-blind, controlled, parallel-group, prospective, multicenter, multinational, interventional study, subjects were randomized equally into four treatment groups. In addition, infants who had been exclusively breastfed (never received any infant formula) since birth and whose mothers intended to continue exclusive breastfeeding until at least 4 months of age were included in the breastfeeding reference group. A total of 350 subjects were enrolled, of which 280 subjects were randomly given any of the four test products and 70 subjects were included in the breastfeeding reference group.
[0087] Test Group 1: Infant Formula 1 is a modified cow's milk-based infant formula (Nutrilon 1 , marketed by Nutr...
Embodiment 2
[0104] Example 2: Consumption of infant formula comprising non-replicating lactic acid producing bacteria selected from Bifidobacterium breve and Streptococcus thermophilus and non-digestible oligosaccharides increases intestinal sIgA levels
[0105] In a randomized, multicenter, double-blind, prospective clinical trial, infants were enrolled before 28 days of age and assigned to receive one of three formulas until 17 weeks of age:
[0106] Test group 1: Infant formula 1 contains 66kcal per 100ml, 1.35g protein (bovine whey protein / casein, weight ratio is 1 / 1), 8.2g digestible carbohydrates (of which 5.6g lactose and 2.1g maltodextrin) , 3.0g fat (mainly vegetable fat), 0.8g contains scGOS in a weight ratio of 9:1 (source GOS) and lcFOS (source ) non-digestible oligosaccharides. On a dry weight basis, approximately 50% in this infant formula is derived from Lactofidus TM , a commercially available infant formula sold under the trade name Gallia. Lactofidus TM is a ferme...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com